Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects on Sublingual Microcirculation of IgGAM Immunoglobulins (Pentaglobin®) in Severe Septic/Septic Shock Patients: a Randomized Controller Trial.

NCT02655133 is registered in ClinicalTrials.gov with Università Politecnica delle Marche as lead sponsor.

NCT NCT02655133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02655133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects on Sublingual Microcirculation of IgGAM Immunoglobulins (Pentaglobin®) in Severe Septic/Septic Shock Patients: a Randomized Controller Trial.
Lead sponsor
Università Politecnica delle Marche
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2016
Completion date
January 1, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock, severe sepsis